BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
28 hedge funds and large institutions have $4.48M invested in Bellicum Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$52.1K | |
2 | +$16.8K | |
3 | +$2.29K | |
4 |
BlackRock
New York
|
+$930 |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$421 |
Top Sellers
1 | -$54K | |
2 | -$47K | |
3 | -$12.1K | |
4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$9.48K |
5 |
BFM
Boothbay Fund Management
New York
|
-$9.45K |